PACE-CME

Unhiding hypertrophic cardiomyopathy, a call for action

Unhiding hypertrophic cardiomyopathy a call for action
RestartResume
10' education - Sep. 28, 2022 - Antonis Pantazis, MD

Subtitles: English, French, German & more

  • Overview

    Antonis Pantazis talks about the characteristics of hypertrophic cardiomyopathy and shares some action points to improve care for patients with this disease.

  • Educational information

    This lecture by Antonis Pantazis was part of the EBAC-accredited symposium "Innovative therapeutic approaches in hypertrophic cardiomyopathy" held during the ESC congress 2022.

  • Faculty

    Antonis Pantazis is a Consultant Cardiologist and Clinical Lead for the Cardiomyopathy and the Inherited Cardiovascular Conditions Service at the Royal Brompton and Harefield Hospitals in London. Dr Pantazis is the Chairman of the nucleus of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. In his clinical practice, he has a special interest in the genetic diagnosis, deep phenotyping and patient-centred management of cardiomyopathies. He is leading a programme for the management of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy.

  • Disclosures

    This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

  • Funding

    Funding for this educational program was provided by an unrestricted educational grant from Bristol Myers Squibb.

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments

Register

We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free